Midsummer Investment

Midsummer Capital is a private investment firm and hedge fund that specializes in providing growth capital to small-cap and micro-cap companies, with a significant historical focus on the life sciences and biotechnology sectors. The firm primarily engages in Private Investment in Public Equity (PIPE) transactions, offering structured financing solutions to emerging healthcare companies to advance their clinical trials and corporate development. While Midsummer Capital does not develop its own therapeutic products, it has been a frequent participant in the financing rounds of numerous oncology, rare disease, and medical device companies. The firm's strategic investments have provided essential liquidity for many biotech entities during critical stages of their development cycles.